Source: FinanzNachrichten

AOBiome: Biorasi, LLC: Biorasi Featured in AOBiome B244 Clinical Study Report in The Lancet's eClinicalMedicine

MIAMI, FL / ACCESSWIRE / May 16, 2023 / Biorasi, a leading global full-service contract research organization (CRO), is proud to announce our inclusion in AOBiome Therapeutics' report on Phase 2b c...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Todd Krueger's photo - President of AOBiome

President

Todd Krueger

CEO Approval Rating

73/100

Read more